Latest Prescription Drugs news
RAAS Inhibitors May Cut Risk for Rupture in Brain Aneurysm
posted June 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
New Drug Launch Prices Increasing Exponentially Each Year
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASCO: Ramucirumab Plus Pembrolizumab Promising in NSCLC
posted June 9th
by modernClinician Editorial Team
by modernClinician Editorial Team
ASCO: Desmoplastic Melanoma Responds to Neoadjuvant Pembrolizumab
posted June 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus Monthly Specialist Briefings
Stay Connected
